Characterization of an HLA-C-restricted CTL response in chronic HIV infection

European Journal of Immunology

Volumn 40, Issue 4, 2010, Pages 1036-1041

  Makadzange, Azure T ^a,b   Gillespie, Geraldine ^a   Dong, Tao ^a   Kiama, Peter ^c   Bwayo, Job ^c   Kimani, Joshua ^c   Plummer, Frank ^c   Easterbrook, Philippa ^d   Rowland Jones, Sarah L ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF NAIROBI   (Kenya)

^d QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

CTL; HIV; HLA C; MHC; T cell differentiation

Indexed keywords

CD27 ANTIGEN; CD28 ANTIGEN; EPITOPE; GAMMA INTERFERON; HLA A ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; PERFORIN;

ALLELE; ANTIGEN EXPRESSION; ANTIVIRAL THERAPY; ARTICLE; CD4 LYMPHOCYTE COUNT; CELL FUNCTION; CLINICAL ARTICLE; ENZYME LINKED IMMUNOSPOT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEMORY CELL; PHENOTYPE; PRIORITY JOURNAL;

AFRICAN CONTINENTAL ANCESTRY GROUP; ANTIGENS, CD27; ANTIGENS, CD28; CD4 LYMPHOCYTE COUNT; CHRONIC DISEASE; COHORT STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FLOW CYTOMETRY; HIV ANTIGENS; HIV INFECTIONS; HIV-1; HLA-C ANTIGENS; HUMANS; IMMUNODOMINANT EPITOPES; IMMUNOLOGIC MEMORY; IMMUNOPHENOTYPING; INTERFERON-GAMMA; NEF GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 77951072789     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.200939634     Document Type: Article

References (27)

1. Koup, R. A., Safrit, J. T., Cao, Y., Andrews, C. A., McLeod, G., Borkowsky, W., Farthing, C. and Ho, D. D., Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J. Virol. 1994. 68: 4650-4655. (Pubitemid 24183063)
2. Harrer, E., Harrer, T., Buchbinder, S., Mann, D. L., Feinberg, M., Yilma, T., Johnson, R. P. and Walker, B. D., HIV-1-specific cytotoxic T lymphocyte response in healthy, long-term nonprogressing seropositive persons. AIDS Res. Hum. Retroviruses 1994. 10: S77-78.
3. Rinaldo, C., Huang, X. L., Fan, Z. F., Ding, M., Beltz, L., Logar, A., Panicali, D. et al., High levels of anti-human immunodeficiency virus type 1 (HIV-1) memory cytotoxic T-lymphocyte activity and low viral load are associated with lack of disease in HIV-1-infected long-term nonprogressors. J. Virol. 1995. 69: 5838-5842.
4. Ogg, G. S., Jin, X., Bonhoeffer, S., Dunbar, P. R., Nowak, M. A., Monard, S., Segal, J. P. et al., Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. Science 1998. 279: 2103-2106. (Pubitemid 28196353)
5. Thananchai, H., Makadzange, T., Maenaka, K., Kuroki, K., Peng, Y., Conlon, C., Rowland-Jones, S. and Dong, T., Reciprocal recognition of an HLA-Cw4-restricted HIV-1 gp120 epitope by CD8+ T cells and NK cells. AIDS 2009. 23: 189-193.
6. Neisig, A., Melief, C. J. and Neefjes, J., Reduced cell surface expression of HLA-C molecules correlates with restricted peptide binding and stable TAP interaction. J. Immunol. 1998. 160: 171-179. (Pubitemid 28116727)
7. McCutcheon, J. A., Gumperz, J., Smith, K. D., Lutz, C. T. and Parham, P., Low HLA-C expression at cell surfaces correlates with increased turnover of heavy chain mRNA. J. Exp. Med. 1995. 181: 2085-2095.
8. Wilson, C. C., Kalams, S. A.,Wilkes, B. M., Ruhl, D. J., Gao, F., Hahn, B. H., Hanson, I. C. et al., Overlapping epitopes in human immunodeficiency virus type 1 gp120 presented by HLA A, B, and C molecules: effects of viral variation on cytotoxic T-lymphocyte recognition. J. Virol. 1997. 71: 1256-1264. (Pubitemid 27030299)
9. Rauch, A., Laird, R., McKinnon, E., Telenti, A., Furrer, H., Weber, R., Smillie, D. and Gaudieri, S., Influence of inhibitory killer immunoglobulin-like receptors and their HLA-C ligands on resolving hepatitis C virus infection. Tissue Antigens 2007. 69: 237-240. (Pubitemid 46625892)
10. Fellay, J., Shianna, K. V., Ge, D., Colombo, S., Ledergerber, B., Weale, M., Zhang, K. et al., A whole-genome association study of major determinants for host control of HIV-1. Science 2007. 317: 944-947. (Pubitemid 47301321)
11. Johnson, R. P., Trocha, A., Buchanan, T. M. andWalker, B. D., Recognition of a highly conserved region of human immunodeficiency virus type 1 gp120 by an HLA-Cw4-restricted cytotoxic T-lymphocyte clone. J. Virol. 1993. 67: 438-445.
12. Marsh, S. G. E., Parham, P. and Barber, L., The HLA Facts Book, Academic Press, London 2000.
13. Matthews, P. C., Prendergast, A., Leslie, A., Crawford, H., Payne, R., Rousseau, C., Rolland, M. et al., Central role of reverting mutations in HLA associations with human immunodeficiency virus set point. J. Virol. 2008. 82: 8548-8559.
14. Appay, V., Dunbar, P. R., Callan, M., Klenerman, P., Gillespie, G. M., Papagno, L., Ogg, G. S. et al., Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections. Nat. Med. 2002. 8: 379-385.
15. Cao, Y., Qin, L., Zhang, L., Safrit, J. and Ho, D. D., Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection. N. Engl. J. Med. 1995. 332: 201-208.
16. Carmichael, A., Jin, X., Sissons, P. and Borysiewicz, L., Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease. J. Exp. Med. 1993. 177: 249-256.
17. Cohen, G. B., Gandhi, R. T., Davis, D. M., Mandelboim, O., Chen, B. K., Strominger, J. L. and Baltimore, D., The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells. Immunity 1999. 10: 661-671. (Pubitemid 29302919)
18. Collins, K. L., Chen, B. K., Kalams, S. A., Walker, B. D. and Baltimore, D., HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes. Nature 1998. 391: 397-401. (Pubitemid 28093515)
19. Goulder, P. J., Bunce, M., Luzzi, G., Phillips, R. E. and McMichael, A. J., Potential underestimation of HLA-C-restricted cytotoxic T-lymphocyte responses. AIDS 1997. 11: 1884-1886. (Pubitemid 27500968)
20. Adnan, S., Balamurugan, A., Trocha, A., Bennett, M. S., Ng, H. L., Ali, A., Brander, C. and Yang, O. O., Nef interference with HIV-1-specific CTL antiviral activity is epitope specific. Blood 2006. 108: 3414-3419.
21. Appay, V., Nixon, D. F., Donahoe, S. M., Gillespie, G. M., Dong, T., King, A., Ogg, G. S. et al., HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function. J. Exp. Med. 2000. 192: 63-75.
22. Trimble, L. A., Kam, L. W., Friedman, R. S., Xu, Z. and Lieberman, J., CD3zeta and CD28 down-modulation on CD8 T cells during viral infection. Blood 2000. 96: 1021-1029. (Pubitemid 30616869)
23. Ehl, S., Hombach, J., Aichele, P., Rulicke, T., Odermatt, B., Hengartner, H., Zinkernagel, R. and Pircher, H., Viral and bacterial infections interfere with peripheral tolerance induction and activate CD8+ T cells to cause immunopathology. J. Exp. Med. 1998. 187: 763-774.
24. Bunce, M., O'Neill, C. M., Barnardo, M. C., Krausa, P., Browning, M. J., Morris, P. J. andWelsh, K. I., Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP). Tissue Antigens 1995. 46: 355-367.
25. Zemmour, J., Little, A. M., Schendel, D. J. and Parham, P., The HLA-A,B "negative" mutant cell line C1R expresses a novel HLA-B35 allele, which also has a point mutation in the translation initiation codon. J. Immunol. 1992. 148: 1941-1948.
26. Fan, Q. R., Garboczi, D. N., Winter, C. C., Wagtmann, N., Long, E. O. and Wiley, D. C., Direct binding of a soluble natural killer cell inhibitory receptor to a soluble human leukocyte antigen-Cw4 class I major histocompatibility complex molecule. Proc. Natl. Acad. Sci. USA 1996. 93: 7178-7183.
27. Lalvani, A., Dong, T., Ogg, G., Patham, A. A., Newell, H., Hill, A. V., McMichael, A. J. and Rowland-Jones, S., Optimization of a peptide-based protocol employing IL-7 for in vitro restimulation of human cytotoxic T lymphocyte precursors. J. Immunol. Methods 1997. 210: 65-77. (Pubitemid 127445152)